[Chronic cor pulmonale in pulmonary tuberculosis and its treatment]. 1989

A I Ershov, and Iu A Evsta'fev, and A O Ma'riandyshev, and Z A Permiakova, and L P Alekseeva

New data on the pathogenesis of chronic cor pulmonale were obtained. The reduction of pulmonary capillaries at the site of the tuberculosis process beyond this site was found to contribute much to the development of pulmonary artery hypertension. Irreversible injuries to the vessels are due to both the pneumosclerotic changes and the specific circulating immune complexes (CIC) effects. Acting on the peripheral veins (in Koch's test), CICs influence the central hemodynamics, decreasing circulating blood volume by 30-40% and reducing cardiac output, thus resulting in deficit of the blood inflow to the right compartments of the heart. In this case the atrium functions at a higher load, like a suction pump, thus leading to cardiac hypertrophy. Peripheral vasodilators (apressin, nitrong) combined with cardiac glycosides (digoxin), favorably influencing the central hemodynamics, are recommended for the prevention and treatment of chronic cor pulmonale.

UI MeSH Term Description Entries
D009566 Nitrates Inorganic or organic salts and esters of nitric acid. These compounds contain the NO3- radical. Nitrate
D011660 Pulmonary Heart Disease Hypertrophy and dilation of the RIGHT VENTRICLE of the heart that is caused by PULMONARY HYPERTENSION. This condition is often associated with pulmonary parenchymal or vascular diseases, such as CHRONIC OBSTRUCTIVE PULMONARY DISEASE and PULMONARY EMBOLISM. Cor Pulmonale,Disease, Pulmonary Heart,Diseases, Pulmonary Heart,Heart Disease, Pulmonary,Heart Diseases, Pulmonary,Pulmonary Heart Diseases
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014397 Tuberculosis, Pulmonary MYCOBACTERIUM infections of the lung. Pulmonary Consumption,Pulmonary Phthisis,Pulmonary Tuberculoses,Pulmonary Tuberculosis,Tuberculoses, Pulmonary,Consumption, Pulmonary,Consumptions, Pulmonary,Phthises, Pulmonary,Phthisis, Pulmonary,Pulmonary Consumptions,Pulmonary Phthises

Related Publications

A I Ershov, and Iu A Evsta'fev, and A O Ma'riandyshev, and Z A Permiakova, and L P Alekseeva
March 1952, Acta medica Scandinavica,
A I Ershov, and Iu A Evsta'fev, and A O Ma'riandyshev, and Z A Permiakova, and L P Alekseeva
January 1962, Neumologia y cirugia de torax,
A I Ershov, and Iu A Evsta'fev, and A O Ma'riandyshev, and Z A Permiakova, and L P Alekseeva
June 1969, The Journal of the Association of Physicians of India,
A I Ershov, and Iu A Evsta'fev, and A O Ma'riandyshev, and Z A Permiakova, and L P Alekseeva
June 1956, Jornal do medico,
A I Ershov, and Iu A Evsta'fev, and A O Ma'riandyshev, and Z A Permiakova, and L P Alekseeva
January 1990, Sovetskaia meditsina,
A I Ershov, and Iu A Evsta'fev, and A O Ma'riandyshev, and Z A Permiakova, and L P Alekseeva
January 1958, Schweizerische medizinische Wochenschrift,
A I Ershov, and Iu A Evsta'fev, and A O Ma'riandyshev, and Z A Permiakova, and L P Alekseeva
September 1966, La Clinica terapeutica,
A I Ershov, and Iu A Evsta'fev, and A O Ma'riandyshev, and Z A Permiakova, and L P Alekseeva
November 1956, Der Tuberkulosearzt,
A I Ershov, and Iu A Evsta'fev, and A O Ma'riandyshev, and Z A Permiakova, and L P Alekseeva
December 1953, Nordisk medicin,
A I Ershov, and Iu A Evsta'fev, and A O Ma'riandyshev, and Z A Permiakova, and L P Alekseeva
December 1956, Wiener Zeitschrift fur innere Medizin und ihre Grenzgebiete,
Copied contents to your clipboard!